PLUS1
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ESSA Pharma Inc | EPIX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.07 | -1.22% | 5.66 | 5.70 | 5.60 | 5.70 | 5.73 | 09:45:32 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 5.60 | 5.69 | 0.09 | 1.58% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6 | 1,404 | $ 5.69 | $ 7,984 | 32,655 | 1.41 - 6.1372 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:31:19 | 100 | $ 5.66 | USD |
ESSA Pharma Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 117.52M | 20.76M | $ -11.63M | - | - | 20.82M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
ESSA Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/20/2019 | 06:03 | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) |
| 12/20/2019 | 06:02 | Edgar (US Regulatory) | Annual and Transition Report (foreign Private Issuer) (20-f) |
| 12/19/2019 | 17:15 | PR Newswire (Canada) | ESSA Pharma Provides Corporate Update and Reports Financial.. |
| 12/12/2019 | 11:35 | GlobeNewswire Inc. | Janpix, Inc. Announces Appointment of Sanford (Sandy).. |
| 11/12/2019 | 14:32 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) |
| 11/06/2019 | 06:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 11/05/2019 | 13:19 | Edgar (US Regulatory) | Securities Registration (foreign Private Issuer) (f-3/a) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EPIX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.84 | 5.94 | 5.60 | 5.71 | 29,785 | -0.18 | -3.08% |
| 1 Month | 5.47 | 5.94 | 5.00 | 5.66 | 21,913 | 0.19 | 3.47% |
| 3 Months | 4.69 | 6.1372 | 3.7709 | 5.09 | 39,557 | 0.97 | 20.68% |
| 6 Months | 2.88 | 6.1372 | 1.41 | 3.82 | 39,047 | 2.78 | 96.53% |
| 1 Year | 4.18 | 6.1372 | 1.41 | 3.69 | 23,996 | 1.48 | 35.41% |
| 3 Years | 1.95 | 6.1372 | 0.10 | 1.03 | 55,154 | 3.71 | 190.26% |
| 5 Years | 8.30 | 11.69 | 0.10 | 1.14 | 41,727 | -2.64 | -31.81% |
ESSA Pharma Description
| ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. |
